 MINNEAPOLIS, MN ACCESSWIRE August 4, 2022 Celcuity Inc. NASDAQ:CELC, a clinical-stage biotechnology company focused on development of targeted therapies for hormonally driven cancers, today announced that it will release its financial results for the second quarter 2022 after the stock market close on Thursday, August 11, 2022. Management will host a webcastteleconference the same day at 4:30 p.m. 